← Evidence map

ArticlePituitary2026

Authors' reply to the letter to the editor by Fedai et al.: "Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort".

Kevin C J Yuen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Authors' reply to the letter to the editor by Fedai et al.: "Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort". | OpenQuestion